⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL83844 | 0.97 | — | — | |
| Iodide SCHEMBL902785 | 0.97 | — | — | |
| SCHEMBL28016430 | 0.94 | TSHR (0.33) | — | |
| SCHEMBL21305079 | 0.94 | HIF1A (0.35) | — | |
| SCHEMBL28196800 | 0.89 | TSHR (0.31) | — | |
| SCHEMBL26740945 | 0.89 | TSHR (0.31) | — | |
| SCHEMBL26460935 | 0.87 | CXCR4 (0.45) | — | |
| SCHEMBL14543405 | 0.85 | TSHR (0.32) | — | |
| SCHEMBL26157 | 0.81 | — | — | |
| Water SCHEMBL21001070 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 791 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250002475-A1 | PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS | EPICS THERAPEUTICS (BE) | 2025-01-02 | — | — | US | claimed |
| US-12091400-B2 | Piperidine derivatives as METTL3 inhibitors | EPICS THERAPEUTICS (BE) | 2024-09-17 | — | — | US | claimed |
| US-20240270716-A1 | PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS | EPICS THERAPEUTICS (BE) | 2024-08-15 | — | — | US | claimed |
| EP-3814323-A1 | HYDROGENATION PROCESS | Johnson Matthey Public Limited Company (GB) | 2021-05-05 | — | — | EP | claimed |
| CN-105378870-A | Nonaqueous electrolyte solution for electric double layer capacitor | OTSUKA CHEMICAL CO LTD | 2016-03-02 | — | — | CN | claimed |
| EP-2885279-A1 | CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | Janssen Pharmaceutica, N.V. (BE) | 2015-06-24 | — | — | EP | claimed |
| US-20150158020-A1 | SYNTHESIS OF ZEOLITES USING AN ORGANOAMMONIUM COMPOUND | UOP LLC | 2015-06-11 | — | — | US | claimed |
| WO-2014028801-A1 | CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-20 | — | — | WO | claimed |
| WO-2013177292-A1 | TITANIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2013-11-28 | — | — | WO | claimed |
| WO-2013177284-A1 | HAFNIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2013-11-28 | — | — | WO | claimed |
| WO-1996028152-A1 | NOVEL BENZOFURAN PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1996-09-19 | — | — | WO | claimed |
| EP-0731101-A1 | 3-Benzyl-benzothiophenes | ELI LILLY AND COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0731100-A1 | Benzothiophene pharmaceutical compounds | ELI LILLY AND COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0731093-A1 | Naphthyl pharmaceutical compounds | ELI LILLY AND COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0731097-A1 | Novel benzofuran pharmaceutical compounds | ELI LILLY AND COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0731098-A1 | Alpha-substituted-3-benzyl-benzofurans | ELI LILLY AND COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| US-5523309-A | ALLEVIATING THE SYMPTOMS OF POST-MENOPAUSAL SYNDROME | ELI LILLY AND COMPANY (US) | 1996-06-04 | — | — | US | claimed |
| JP-H08504200-A | — | — | 1996-05-07 | — | — | JP | claimed |
| EP-0672037-A1 | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK-MODULATORS | GLAXO GROUP LIMITED (GB) | 1995-09-20 | — | — | EP | claimed |
| WO-1994013648-A1 | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK-MODULATORS | GLAXO GROUP LIMITED (GB) | 1994-06-23 | — | — | WO | claimed |